Literature DB >> 16972015

Molecular and functional diversity of vascular endothelial growth factors.

Yasuo Yamazaki1, Takashi Morita.   

Abstract

Members of the vascular endothelial growth factor (VEGF) family are crucial regulators of neovascularization and are classified as cystine knot growth factors that specifically bind cellular receptor tyrosine kinases VEGFR-1, VEGFR-2, and VEGFR-3 with high but variable affinity and selectivity. The VEGF family has recently been expanded and currently comprises seven members: VEGF-A, VEGF-B, placenta growth factor (PlGF), VEGF-C, VEGF-D, viral VEGF (also known as VEGF-E), and snake venom VEGF (also known as VEGF-F). Although all members are structurally homologous, there is molecular diversity among the subtypes, and several isoforms, such as VEGF-A, VEGF-B, and PlGF, are generated by alternative exon splicing. These splicing isoforms exhibit differing properties, particularly in binding to co-receptor neuropilins and heparin. VEGF family proteins play multiple physiological roles, such as angiogenesis and lymphangiogenesis, while exogenous members (viral and snake venom VEGFs) display activities that are unique in physiology and function. This review will highlight the molecular and functional diversity of VEGF family proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16972015     DOI: 10.1007/s11030-006-9027-3

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   3.364


  155 in total

1.  Crotalid venom vascular endothelial growth factors has preferential affinity for VEGFR-1. Characterization of Protobothrops mucrosquamatus venom VEGF.

Authors:  Yuh-Ling Chen; Inn-Ho Tsai; Tse-Ming Hong; Shu-Huei Tsai
Journal:  Thromb Haemost       Date:  2005-02       Impact factor: 5.249

2.  Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers.

Authors:  S A Stacker; K Stenvers; C Caesar; A Vitali; T Domagala; E Nice; S Roufail; R J Simpson; R Moritz; T Karpanen; K Alitalo; M G Achen
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

3.  Pathophysiological consequences of VEGF-induced vascular permeability.

Authors:  Sara M Weis; David A Cheresh
Journal:  Nature       Date:  2005-09-22       Impact factor: 49.962

4.  Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.

Authors:  T Veikkola; L Jussila; T Makinen; T Karpanen; M Jeltsch; T V Petrova; H Kubo; G Thurston; D M McDonald; M G Achen; S A Stacker; K Alitalo
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

5.  Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform.

Authors:  B Olofsson; K Pajusola; G von Euler; D Chilov; K Alitalo; U Eriksson
Journal:  J Biol Chem       Date:  1996-08-09       Impact factor: 5.157

6.  Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor.

Authors:  C Wiesmann; G Fuh; H W Christinger; C Eigenbrot; J A Wells; A M de Vos
Journal:  Cell       Date:  1997-11-28       Impact factor: 41.582

7.  A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.

Authors:  M Meyer; M Clauss; A Lepple-Wienhues; J Waltenberger; H G Augustin; M Ziche; C Lanz; M Büttner; H J Rziha; C Dehio
Journal:  EMBO J       Date:  1999-01-15       Impact factor: 11.598

8.  Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

Authors:  Aernout Luttun; Marc Tjwa; Lieve Moons; Yan Wu; Anne Angelillo-Scherrer; Fang Liao; Janice A Nagy; Andrea Hooper; Josef Priller; Bert De Klerck; Veerle Compernolle; Evis Daci; Peter Bohlen; Mieke Dewerchin; Jean-Marc Herbert; Roy Fava; Patrick Matthys; Geert Carmeliet; Désiré Collen; Harold F Dvorak; Daniel J Hicklin; Peter Carmeliet
Journal:  Nat Med       Date:  2002-07-01       Impact factor: 53.440

9.  Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus.

Authors:  D J Lyttle; K M Fraser; S B Fleming; A A Mercer; A J Robinson
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

Review 10.  Vasculogenesis.

Authors:  W Risau; I Flamme
Journal:  Annu Rev Cell Dev Biol       Date:  1995       Impact factor: 13.827

View more
  70 in total

1.  VEGFA family isoforms regulate spermatogonial stem cell homeostasis in vivo.

Authors:  Kyle C Caires; Jeanene M de Avila; Andrea S Cupp; Derek J McLean
Journal:  Endocrinology       Date:  2011-12-06       Impact factor: 4.736

2.  Expression of vascular endothelial growth factor receptor-3 mRNA in the developing rat cerebellum.

Authors:  Yun Hou; Jeong-Sun Choi; Yoo-Jin Shin; Jung-Ho Cha; Jae-Youn Choi; Myung-Hoon Chun; Mun-Yong Lee
Journal:  Cell Mol Neurobiol       Date:  2010-11-12       Impact factor: 5.046

3.  An Emerging Role for Angiogenesis in Tendinopathy.

Authors:  Alexander Scott; Patrik Danielson
Journal:  Eur Musculoskelet Rev       Date:  2009-01-01

4.  Lymphatic vessel density and VEGF-C expression are significantly different among benign and malignant thyroid lesions.

Authors:  Eduardo Anselmo Garcia; Kleber Simões; Alda Wakamatsu; Rodrigo Albergaria Ressio; Venâncio Avancini Ferreira Alves; Adhemar Longatto-Filho; Roberto Souza Camargo
Journal:  Endocr Pathol       Date:  2010-06       Impact factor: 3.943

5.  Blockade of angiopoietin-2/Tie2 signaling pathway specifically promotes inflammation-induced angiogenesis in mouse cornea.

Authors:  Zhi-Xin Yan; Yi Luo; Ning-Fei Liu
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

6.  VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine.

Authors:  Eric V Yang; Elise L Donovan; Don M Benson; Ronald Glaser
Journal:  Brain Behav Immun       Date:  2007-11-05       Impact factor: 7.217

7.  VEGF expression in patellar tendinopathy: a preliminary study.

Authors:  Alexander Scott; Øystein Lian; Roald Bahr; David A Hart; Vincent Duronio
Journal:  Clin Orthop Relat Res       Date:  2008-05-06       Impact factor: 4.176

8.  Vascular endothelial growth factor-C: its unrevealed role in fibrogenesis.

Authors:  Tieqiang Zhao; Wenyuan Zhao; Weixin Meng; Chang Liu; Yuanjian Chen; Yao Sun
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-24       Impact factor: 4.733

9.  Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle.

Authors:  Andrey Anisimov; Annamari Alitalo; Petra Korpisalo; Jarkko Soronen; Seppo Kaijalainen; Veli-Matti Leppänen; Michael Jeltsch; Seppo Ylä-Herttuala; Kari Alitalo
Journal:  Circ Res       Date:  2009-05-14       Impact factor: 17.367

10.  VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis.

Authors:  Todd R Wuest; Daniel J J Carr
Journal:  J Exp Med       Date:  2009-12-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.